News for 'Nandini Piramal'

Nandini Piramal to join dad's firm

Nandini Piramal to join dad's firm

Rediff.com14 Jun 2006

Nandini Piramal gallops away in the OTC business

Nandini Piramal gallops away in the OTC business

Rediff.com13 Jul 2017

'Younger people are taking steps to prevent lifestyle diseases.'
'It is fascinating to partner with consumers on the journey of self-discovery and to help shape people's preferences -- that is what I find most exciting,' Nandini Piramal tells Abhineet Kumar and Aneesh Phadnis.

Piramal Pharma looks to return on growth path

Piramal Pharma looks to return on growth path

Rediff.com8 May 2026

Piramal Pharma anticipates a significant turnaround in financial year 2026-27 (FY27), projecting early-to-mid teens revenue expansion and a sharp improvement in profitability, driven by improved business momentum, new product acquisitions, and structural tailwinds.

'UP Has Potential To Generate More Than 11 Million Jobs'

'UP Has Potential To Generate More Than 11 Million Jobs'

Rediff.com1 Sep 2026

'Improved law and order and transparent governance have helped change UP's investment image.'

'We will not sell Piramal Healthcare'

'We will not sell Piramal Healthcare'

Rediff.com26 Oct 2009

Nandini Piramal, heir apparent to the Piramal business empire as the elder child of Ajay Piramal and Swati Piramal, became the executive director of Piramal Healthcare in April this year. A 29-year-old graduate from Hertford College of Oxford University, with an MBA from the Stanford Graduate School of Business, she joined the firm in 2006 as a General Manager and has been closely associated with the company's overseas subsidiaries in the US and Canada.

Post SC ruling, Piramal readies big plans for Saridon

Post SC ruling, Piramal readies big plans for Saridon

Rediff.com21 Feb 2019

This ruling means that we will continue to invest in the brand and we will also look at launching line extensions over the next calendar year, said Nandini Piramal.

Anand Piramal, Mukesh Ambani's future son-in-law

Anand Piramal, Mukesh Ambani's future son-in-law

Rediff.com10 May 2018

The Harvard alum has known the Yale alum for ages, but hit it off recently.

Anant Goenka to be Ceat deputy MD

Anant Goenka to be Ceat deputy MD

Rediff.com22 Dec 2009

The move comes on the back of a series of next generation family members taking over the reins from current promoters. Roshni Nadar, daughter of HCL founder Shiv Nadar, took over as CEO of the company in July. Nandini Piramal, eldest child of Ajay and Swati Piramal, became executive director of Piramal Healthcare in April.

Ambani's twin kids made directors of Rel Jio & retail ventures

Ambani's twin kids made directors of Rel Jio & retail ventures

Rediff.com11 Oct 2014

Isha and Akash, 23, were appointed to the boards of Reliance Jio Infocomm Ltd and Reliance Retail Ventures Ltd, the company said.

How Saridon has managed to remain top of the mind

How Saridon has managed to remain top of the mind

Rediff.com3 May 2019

What has worked though for Brand Saridon has been its single-minded focus on headaches as opposed to other analgesics that dwell on a wider set of problems, reports Sohini Das.

'Whatever we do, we have to make an impact'

'Whatever we do, we have to make an impact'

Rediff.com26 Jun 2023

'Professors can teach even when they are 90 because they don't lose their skill with words. Go deeper and there's spirituality in it.'

Lenders retain AIF holdings even as RBI deadline nears

Lenders retain AIF holdings even as RBI deadline nears

Rediff.com24 Jan 2024

Alternative investment funds (AIFs) have not seen any significant redemptions from financial institutions even though the 30-day timeline provided by the Reserve Bank of India (RBI) to liquidate their holdings or make full provisions ends recently. Sources said the industry is awaiting certain relaxations or extensions based on the recommendations submitted to the banking regulator. On December 19, the RBI restricted financial institutions and banks from investing in AIFs where there is any downstream link or exposure to a debtor firm.